Antonino Carbone

ALK+ lymphoma: clinico-pathological findings and outcome.

Brunangelo Falini, Stefano Pileri, Pier Luigi Zinzani et al. · PubMed · 1999 · 567 citations

Medicine, Oncology, Pathology +12

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 565 citations

Medicine, Oncology, Surgery +17

A multicenter study of treatment of primary CNS lymphoma

Andrés J.M. Ferreri, Michele Reni, Felice Pasini et al. · Neurology · 2002 · 365 citations

Medicine, Oncology, Pharmacotherapy +11

EML4-ALK Rearrangement in Non-Small Cell Lung Cancer and Non-Tumor Lung Tissues

Maria Paola Martelli, Gabriella Sozzi, Luís Hernández et al. · American Journal Of Pathology · 2009 · 317 citations · Full text

Medicine, Molecular Biology, Oncology +14

ALK Expression Defines a Distinct Group of T/Null Lymphomas (“ALK Lymphomas”) with a Wide Morphological Spectrum

Brunangelo Falini, Barbara Bigerna, Marco Fizzotti et al. · American Journal Of Pathology · 1998 · 275 citations · Full text

Veterinary Medicine, Oncology, Pathology +16